Premier Medical Corporation
Premier Medical Corporation is a global leader in developing cost-effective Point-of-Care rapid diagnostic tests for infectious diseases, cancer screening, and cardiac markers. Established in 1996, it has a strong presence in over 100 countries, with a focus on quality, innovation, and affordability. The company is ISO 13485:2016 certified, WHO prequalified, and CE marked, serving diverse customer groups including healthcare professionals, laboratories, hospitals, and government health centers. Its mission is to build a healthier tomorrow through high-quality diagnostic products, and its vision is to become a leader in the global health environment by providing reliable, safe, and user-friendly in vitro diagnostic solutions.
Industries
Nr. of Employees
large (251-1000)
Premier Medical Corporation
Products
Rapid HIV 1/2 card test (professional)
Rapid qualitative screening test for detection of antibodies specific to HIV‑1 and HIV‑2 in whole blood, serum or plasma; intended for use by healthcare professionals and laboratories. Result time ~15–25 minutes.
Rapid HIV 1/2 card test (self-test)
Self-administered rapid qualitative test for detection of HIV antibodies in whole blood; intended for untrained lay users; rapid interpretation time.
Malaria HRP2 antigen rapid card test (P. falciparum)
Rapid qualitative screening test for detection of P. falciparum HRP2 antigen in whole blood; designed for field use, ambient storage and rapid interpretation (~20–30 minutes).
Malaria pLDH/HRP2 combo rapid card test
Combo rapid test detecting pLDH and HRP2 antigens for differentiation of Plasmodium species in whole blood; designed for field and laboratory use.
HIV / Syphilis combo rapid card test
Rapid qualitative screening test for detection of antibodies to HIV (IgG/IgM) and Treponema pallidum in whole blood, serum or plasma; intended for professional and self-test formats (depending on SKU).
Syphilis anti-TP rapid card test
Rapid qualitative screening test for antibodies specific to Treponema pallidum in whole blood, serum or plasma; intended for professional and self-test formats.
Rapid HIV 1/2 card test (professional)
Rapid qualitative screening test for detection of antibodies specific to HIV‑1 and HIV‑2 in whole blood, serum or plasma; intended for use by healthcare professionals and laboratories. Result time ~15–25 minutes.
Rapid HIV 1/2 card test (self-test)
Self-administered rapid qualitative test for detection of HIV antibodies in whole blood; intended for untrained lay users; rapid interpretation time.
Malaria HRP2 antigen rapid card test (P. falciparum)
Rapid qualitative screening test for detection of P. falciparum HRP2 antigen in whole blood; designed for field use, ambient storage and rapid interpretation (~20–30 minutes).
Malaria pLDH/HRP2 combo rapid card test
Combo rapid test detecting pLDH and HRP2 antigens for differentiation of Plasmodium species in whole blood; designed for field and laboratory use.
HIV / Syphilis combo rapid card test
Rapid qualitative screening test for detection of antibodies to HIV (IgG/IgM) and Treponema pallidum in whole blood, serum or plasma; intended for professional and self-test formats (depending on SKU).
Syphilis anti-TP rapid card test
Rapid qualitative screening test for antibodies specific to Treponema pallidum in whole blood, serum or plasma; intended for professional and self-test formats.
Services
Global distribution and procurement supply
Supply and distribution of rapid diagnostic test kits to international markets and public health purchasers, coordination with government and funding agencies.
Technical documentation and training resources
Provision of downloadable technical information, instructions for use, and training materials for healthcare professionals and lay users.
Bulk manufacturing and contract supply
Bulk production and packaging of rapid diagnostic kits with defined MOQs and multiple pack-size SKUs for procurement and programmatic supply.
Global distribution and procurement supply
Supply and distribution of rapid diagnostic test kits to international markets and public health purchasers, coordination with government and funding agencies.
Technical documentation and training resources
Provision of downloadable technical information, instructions for use, and training materials for healthcare professionals and lay users.
Bulk manufacturing and contract supply
Bulk production and packaging of rapid diagnostic kits with defined MOQs and multiple pack-size SKUs for procurement and programmatic supply.
Expertise Areas
- Point-of-care rapid diagnostic test development
- Lateral flow immunoassay development
- In‑vitro diagnostics manufacturing and scale-up
- Regulatory compliance and WHO prequalification
Key Technologies
- Lateral flow immunoassays
- Chromatographic immunoassays
- Antigen detection (HRP2, pLDH, SARS‑CoV‑2 nucleocapsid)
- Antibody detection (IgG/IgM) immunoassays